SCHEMBL6810109

SCHEMBL6810109

CCN1CCN(c2ccncc2-c2nc3cccc(C(N)=O)c3[nH]2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 4/20 0.40
AURKB Q96GD4 3/20 0.40
PARP1 P09874 5/20 0.38
ACHE P22303 1/20 0.37
PARP2 Q9UGN5 2/20 0.37
ATR Q13535 2/20 0.37
NR4A1 P22736 1/20 0.36
ESR2 Q92731 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
HASPIN Q8TF76 1/20 0.36
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
KDR P35968 2/20 0.35
PLK4 O00444 1/20 0.35
CHEK1 O14757 1/20 0.35
DAPK3 O43293 1/20 0.35
MAP4K4 O95819 1/20 0.35
CSF1R P07333 1/20 0.35
RET P07949 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6801999 0.92 AURKB (0.50) AURKAAURKBPARP1PARP2KDR
SCHEMBL6805989 0.89 PARP1 (0.38) AURKAAURKBPARP1PARP2KDR
SCHEMBL6805702 0.88 AURKA (0.48) AURKAAURKBPARP1KDR
SCHEMBL6810101 0.85 AURKB (0.54) AURKAAURKBPARP1PARP2KDR
SCHEMBL3582282 0.79 AURKB (0.61) AURKAAURKBPARP1ACHENR4A1
SCHEMBL6801983 0.78 AURKB (0.68) AURKAAURKBPARP1PARP2KDR
SCHEMBL6805101 0.78 AURKA (0.64) AURKAAURKBPARP1ACHEKDR
SCHEMBL6810121 0.77 HTR1A (0.41) AURKBPARP1KDRCLK4
SCHEMBL6806267 0.76 HTR1A (0.43) AURKAAURKBPARP1KDRCSF1R
SCHEMBL3582849 0.76 AURKB (0.58) AURKAAURKBPARP1ACHENR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696437-B1 Heterocyclically substituted benzimidazoles, the production and application thereof ABBOTT GMBH & CO. KG (DE) 2004-02-24 US disclosed